Loic Hameon

Loic Hameon currently serves as the Head of Business Development & M&A at UCB, a position held since April 2019. Prior to this, Loic held various leadership roles at Sanofi, including VP Business Development for Diabetes & Cardiovascular and Associate Vice President for Diabetes & Metabolism, from March 2013 to March 2019. Experience also includes serving as Vice President of Business Development for Europe at Teva Pharmaceuticals and Senior Director of Corporate Development for Europe at Cephalon, where responsibilities encompassed business development activities across Europe, the Middle East, and Africa. Earlier in career, Loic worked as Chief Operating Officer and Chief Financial Officer at Medicrea USA, overseeing operational management and financial procedures. Educational background includes a Finance degree from EDHEC Business School and an intensive foundation course at Lycee Joffre in Montpellier, France.